The U.S. CDC's Weekly U.S. Influenza Surveillance Report issued on September 24, 2021, found 2.1% of patient visits reported were due to Influenza-like Illness (ILI) during week #37. The percentage of patient visits for ILI remains... READ →
Precision Vaccinations/ September 25th, 2021
Eliminating fake vaccine news with pharmacist, nurse, and physician review.
Sep 25 • 10:02 am CDT
Sep 25 • 9:01 am CDT
The Indian Council of Medical Research ( ICMR ) confirmed on September 24, 2021, it has removed usage of Ivermectin and Hydroxycholoquine from its approved COVID-19 treatment guidelines. Experts at India's did not find enough evidence... READ →
Sep 25 • 8:47 am CDT
The World Health Organization (WHO) welcomed the addition of another therapeutic to the world's arsenal against COVID-19 on September 24, 2021. Two new recommendations regarding the use of neutralizing monoclonal antibodies, casirivimab, and imdevimab, known as... READ →
Sep 24 • 2:29 pm CDT
The U.S. CDC reported today another human infection with an influenza A(H1N2) variant (A(H1N2)v) virus was reported by Ohio. The patient was not hospitalized and has completely recovered from their illness. The patient and the household... READ →
Sep 24 • 11:49 am CDT
China-based Clover Biopharmaceuticals, Ltd. and the Coalition for Epidemic Preparedness Innovations (CEPI) announced on September 22, 2021, that Clover's adjuvanted protein-based COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), achieved the primary efficacy endpoint and secondary efficacy endpoints... READ →
For more articles, try our search.